J. Bousquet, N. Demarteau, J. Mullol
Jun 1, 2005
Citations
7
Influential Citations
73
Citations
Quality indicators
Journal
Allergy
Abstract
Background: Allergic rhinitis was recently classified by the ARIA guidelines as persistent or intermittent. Levocetirizine was shown to improve symptoms and health‐related quality of life of patients with persistent allergic rhinitis in the XPERTTM study, a 6‐month randomized double blind placebo‐controlled trial.